Dawn Christine Maroney Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 week, 1 day ago
Dawn Christine Maroney has an estimated net worth of at least $26.5 million*, as of Dec. 18, 2024. They own 1.6 million shares of ALHC stock. They have sold 703,481 shares of ALHC stock since 2021, for an estimated $8.2 million.
Dawn Christine Maroney $ALHC SEC Form 4 Insider Trading
Dawn Christine Maroney has filed a total of 36 insider trades in $ALHC since 2021. Their most recent trade was a sale of 30,000 shares, made on Dec 16, 2024. Their largest trade was a sale of 127,843 shares, made on Nov 23, 2021. We estimate that they now own 1.6 million shares of $ALHC, worth an estimated $18.3 million.
Insider Trading at $ALHC
There have been a total of 198 insider trades reported at $ALHC since 2021, with 203,000 shares purchased and 49.1 million shares sold. The most active insider traders in $ALHC stock have been Robert Thomas Freeman, Dawn Christine Maroney, and John E Kao. The most recent trade was a sale of 30,000 shares reported by Dawn Christine Maroney (President, Markets), made on Dec 16, 2024.
History of Insider Stock Trades by Dawn Christine Maroney
Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
---|---|---|---|---|
ALHC | Sale | 30,000 | Dec 16, 2024 | Dec. 18, 2024, 5:42 p.m. |
ALHC | Sale | 30,000 | Nov 15, 2024 | Nov. 15, 2024, 9:11 p.m. |
ALHC | Sale | 30,000 | Oct 15, 2024 | Oct. 16, 2024, 5:40 p.m. |
ALHC | Sale | 30,000 | Sep 16, 2024 | Sept. 18, 2024, 4:20 p.m. |
ALHC | Sale | 2,926 | Aug 23, 2024 | Aug. 23, 2024, 5:27 p.m. |
ALHC | Sale | 7,074 | Aug 22, 2024 | Aug. 23, 2024, 5:27 p.m. |
ALHC | Sale | 20,000 | Aug 15, 2024 | Aug. 16, 2024, 4:51 p.m. |
ALHC | Sale | 36,700 | Jul 19, 2024 | July 19, 2024, 8:24 p.m. |
ALHC | Sale | 832 | Jul 18, 2024 | July 19, 2024, 8:24 p.m. |
ALHC | Sale | 23,163 | Jul 17, 2024 | July 19, 2024, 8:24 p.m. |
ALHC | Sale | 39,305 | Jul 18, 2024 | July 19, 2024, 8:24 p.m. |
ALHC | Sale | 300 | Jul 12, 2024 | July 16, 2024, 4:29 p.m. |
ALHC | Sale | 39,700 | Jul 15, 2024 | July 16, 2024, 4:29 p.m. |
ALHC | Sale | 20,000 | Jun 12, 2024 | June 14, 2024, 5:49 p.m. |
ALHC | Sale | 10,151 | Mar 28, 2024 | March 29, 2024, 8 p.m. |
ALHC | Sale | 13,252 | Mar 20, 2024 | March 21, 2024, 5 p.m. |
ALHC | Sale | 15,861 | Mar 19, 2024 | March 21, 2024, 5 p.m. |
ALHC | Sale | 21,537 | Mar 15, 2024 | March 15, 2024, 8 p.m. |
ALHC | Sale | 23,000 | Mar 08, 2024 | March 12, 2024, 6 p.m. |
ALHC | Sale | 7,178 | Mar 29, 2023 | March 31, 2023, 5 p.m. |
ALHC | Sale | 20,006 | Mar 14, 2023 | March 15, 2023, 6 p.m. |
ALHC | Sale | 5,000 | Jan 17, 2023 | Jan. 19, 2023, 7 p.m. |
ALHC | Sale | 4,274 | Dec 21, 2022 | Dec. 22, 2022, 6 p.m. |
ALHC | Sale | 726 | Dec 15, 2022 | Dec. 19, 2022, 7:32 p.m. |
ALHC | Sale | 10,250 | Sep 09, 2022 | Sept. 9, 2022, 9:07 p.m. |
ALHC | Sale | 20,000 | Sep 01, 2022 | Sept. 2, 2022, 4:15 p.m. |
ALHC | Sale | 16,287 | Aug 22, 2022 | Aug. 24, 2022, 5:59 p.m. |
ALHC | Sale | 13,713 | Aug 23, 2022 | Aug. 24, 2022, 5:59 p.m. |
ALHC | Sale | 1,790 | Aug 15, 2022 | Aug. 17, 2022, 6 p.m. |
ALHC | Sale | 20,000 | Aug 01, 2022 | Aug. 2, 2022, 9:24 p.m. |
ALHC | Sale | 25,225 | Jul 07, 2022 | July 8, 2022, 6:44 p.m. |
ALHC | Sale | 14,775 | Jul 08, 2022 | July 8, 2022, 6:44 p.m. |
ALHC | Sale | 2,150 | Jun 16, 2022 | June 17, 2022, 6:11 p.m. |
ALHC | Sale | 13,782 | Jun 02, 2022 | June 2, 2022, 8 p.m. |
ALHC | Sale | 6,681 | Mar 31, 2022 | April 1, 2022, 7:15 p.m. |
ALHC | Sale | 127,843 | Nov 23, 2021 | Nov. 24, 2021, 7:32 p.m. |
$ALHC Executives and Stock Owners with Insider Trades
-
Robert Thomas Freeman, Chief Financial Officer
-
Dawn Christine Maroney, President, Markets
-
John E Kao, Chief Executive Officer
-
Dinesh M. Kumar, Chief Med & Operating Officer
-
Christopher J Joyce, Chief Legal and Admin. Officer
-
Hakan Kardes, Chief Experience Officer
-
Dinesh M. Kumar, Chief Medical Officer
-
Joseph S Konowiecki, Chairman of the Board
-
Hyong Kim, Chief Medical Officer
-
Richard A. Cross, SVP, General Counsel
-
Robert L. Scavo, Chief Information Officer
-
Donald Steven Furman, Chief Clinical Officer
-
Rajesh Shrestha, Pres., New Markets & CBO
-
Sebastian Burzacchi, COO - Mgmt Services Org
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.